Women’s Health

Grenye O’Malley, MD, graduated from NYU School of Medicine. She then completed residency in Internal Medicine at the Icahn School of Medicine at Mount Sinai. During residency, she developed an interest in diabetes management and was involved in research on glucose sensor use in patients with type 1 diabetes during pregnancy. She is now a graduating fellow at Icahn School of Medicine at Mount Sinai where she will be an Assistant Professor later this year. She is participating in multiple large clinical trials involving type 1 diabetes technologies, including a closed-loop artificial pancreas study, a first of its kind assessment of decision support algorithms for patients using multiple daily injections, and a study of continuous glucose monitoring in the elderly.

In this Exclusive Interview transcript, Grenye O'Malley talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about her prenatal diabetes research, the changes that happen for women with type 1 who are pregnant and using insulin pump therapy, and a large multiple trial for the artificial pancreas.

In this Exclusive Interview, Grenye O'Malley talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about the changes that happen for women with type 1 who are pregnant and using insulin pump therapy.

In part 1 of this Exclusive Interview, Grenye O'Malley talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about the challenges faced by women with diabetes who are pregnant and using an insulin pump.

In part 2 of this Exclusive Interview, Grenye O'Malley talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about the findings of the prenatal study of women with diabetes, both before pregnancy and during. Also, the impact of the CGM on pregnancy.

In part 3, the conclusion of this Exclusive Interview, Grenye O'Malley talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about the unique aspects of a new trial that studies the artificial pancreas and the benefits for people on multiple daily injections who may not want to use a pump.

ADA 2018 abstracts of interest include Entresto for the Treatment of Diabetic Peripheral Neuropathy; Oral Contraceptive Associated with Postmenopausal Diabetes; Glucokinase as Adjunct Therapy in People with Type 1 Diabetes, and more.

New research shows how estrogen treatment helps to control blood sugar levels after menopause.

Secondary analysis evaluates effect of Women’s Health Initiative dietary intervention.

Females with breast cancer and diabetes have poorer prognosis than those with breast cancer without diabetes, but why?